Rarely symptoms like shock (nausea, cold sense of limb, dyspnea) may occur. In the case that acknowledged as abnormality, therapy is discontinued and appropriate measures are taken.
Rarely cardiovascular collapse, Apsychia, Angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, rash, urticaria, itching, blepharal flare edema, skin flare and conjunctival injection may occur. In the event of these symptoms, this therapy is discontinued.
Occasionally irritation such as transient burning sense, dysphoria, occasional stinging pain, flare, itching, chemical conjunctivitis and keratitis, circumbulbar or facial edema, foreign body sensation, dazzling, blurred vision, tears, dryness, eye pain, rarely dizziness, corneal disorder such as lamellar keratitis and Stevens-Johnson syndrome that can become toxic epidermal necrolysis may occur. In the event of these symptoms, therapy is discontinued.